Alfresa Holdings Corporation
ALFRYOTCHealthcare● Active
$13.80
+$0.00(+0.00%)
Market Cap$2.5B
P/E Ratio—
52W High$16.81
52W Low$12.42
Alfresa Holdings Corporation (ALFRY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALFRY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$0.34
Revenue
$4.72B
Est. $4.63B · +2.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat Revenue
ALFRY reports quarterly as a OTC-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $0.34 | — | $4.72B | $4.63B | +2.0% |
| — Q1 FY2026 | Feb 9, 2026 | — | $0.73 | — | $5.41B | $5.29B | +2.4% |
| — Q4 FY2025 | Nov 5, 2025 | — | $0.24 | — | $5.23B | — | — |
| — Q3 FY2025 | Aug 8, 2025 | — | $0.19 | — | $5.25B | $5.64B | -6.9% |
| — Q2 FY2025 | May 12, 2025 | — | $0.06 | — | $4.67B | $4.74B | -1.4% |
| — Q1 FY2025 | Feb 6, 2025 | — | $0.40 | — | $5.13B | $4.57B | +12.1% |
| — Q4 FY2024 | Nov 7, 2024 | — | $0.35 | — | $4.94B | — | — |
| — Q3 FY2024 | Aug 5, 2024 | — | $0.15 | — | $4.50B | — | — |
Q2 FY2026
May 13, 2026
EPS Actual
$0.34
EPS Est.
—
EPS Surpr.
—
Revenue
$4.72B
Q1 FY2026
Feb 9, 2026
EPS Actual
$0.73
EPS Est.
—
EPS Surpr.
—
Revenue
$5.41B
Q4 FY2025
Nov 5, 2025
EPS Actual
$0.24
EPS Est.
—
EPS Surpr.
—
Revenue
$5.23B
Q3 FY2025
Aug 8, 2025
EPS Actual
$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$5.25B
Q2 FY2025
May 12, 2025
EPS Actual
$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$4.67B
Q1 FY2025
Feb 6, 2025
EPS Actual
$0.40
EPS Est.
—
EPS Surpr.
—
Revenue
$5.13B
Q4 FY2024
Nov 7, 2024
EPS Actual
$0.35
EPS Est.
—
EPS Surpr.
—
Revenue
$4.94B
Q3 FY2024
Aug 5, 2024
EPS Actual
$0.15
EPS Est.
—
EPS Surpr.
—
Revenue
$4.50B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $776B | $784B | $792B | 2 |
| Q2 FY2026 | $763B | $771B | $780B | 2 |
| Q1 FY2026 | $732B | $740B | $748B | 2 |
| Q4 FY2025 | $817B | $828B | $839B | 2 |
| Q3 FY2025 | $766B | $766B | $767B | 2 |
| Q2 FY2025 | $756B | $758B | $759B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $14.65 | $15.10 | +3.07% |
| — Q1 FY2026 | Feb 9, 2026 | — | $15.14 | $15.14 | +0.00% |
| — Q4 FY2025 | Nov 5, 2025 | — | $12.42 | $12.42 | +0.00% |
| — Q3 FY2025 | Aug 8, 2025 | — | $15.99 | $15.99 | +0.00% |
| — Q2 FY2025 | May 12, 2025 | — | $13.42 | $13.42 | +0.00% |
| — Q1 FY2025 | Feb 6, 2025 | — | $13.42 | $13.42 | +0.00% |
| — Q4 FY2024 | Nov 7, 2024 | — | $13.42 | $13.42 | +0.00% |
| — Q3 FY2024 | Aug 5, 2024 | — | $13.42 | $13.42 | +0.00% |
Q2 FY2026+3.07%
Report Date
May 13, 2026
EPS Beat/Miss
—
Price Before
$14.65
Price After
$15.10
Q1 FY2026+0.00%
Report Date
Feb 9, 2026
EPS Beat/Miss
—
Price Before
$15.14
Price After
$15.14
Q4 FY2025+0.00%
Report Date
Nov 5, 2025
EPS Beat/Miss
—
Price Before
$12.42
Price After
$12.42
Q3 FY2025+0.00%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$15.99
Price After
$15.99
Q2 FY2025+0.00%
Report Date
May 12, 2025
EPS Beat/Miss
—
Price Before
$13.42
Price After
$13.42
Q1 FY2025+0.00%
Report Date
Feb 6, 2025
EPS Beat/Miss
—
Price Before
$13.42
Price After
$13.42
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$13.42
Price After
$13.42
Q3 FY2024+0.00%
Report Date
Aug 5, 2024
EPS Beat/Miss
—
Price Before
$13.42
Price After
$13.42
Beat Rate0 / 8 quarters
Largest Move+3.07% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALFRY ends December
Alfresa Holdings Corporation (ALFRY) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $0.34 (in line with the analyst consensus of —). The next ALFRY earnings date is expected around September 1, 2026.
Each quarter, investors track ALFRY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALFRY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALFRY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALFRY earnings · 4 questionsAlfresa Holdings Corporation's next earnings report is expected around September 1, 2026. ALFRY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALFRY historically reports after market close (AMC).
ALFRY earnings datewhen is ALFRY earningsALFRY next earnings datewhen does ALFRY report earningsALFRY earnings calendar
▸ Source: FMP · Alfresa Holdings Corporation SEC filings · US GAAP · Alfresa Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026